CLX
42
-3
EQT
65
-3
EOG
62
6
CSCO
57
3
EXR
44
4
MAT
30
-2
FIS
48
2
EL
25
-2
MCK
64
2
DOW
62
2
FITB
65
2
STI
49
2
PCG
54
-4
AIV
34
4
PSX
70
-4
GS
62
3
SJM
19
2
PNR
30
-2
CI
45
2
REGN
53
-3
CLX
42
-3
EQT
65
-3
EOG
62
6
CSCO
57
3
EXR
44
4
MAT
30
-2
FIS
48
2
EL
25
-2
MCK
64
2
DOW
62
2
FITB
65
2
STI
49
2
PCG
54
-4
AIV
34
4
PSX
70
-4
GS
62
3
SJM
19
2
PNR
30
-2
CI
45
2
REGN
53
-3
Financhill
Back

Protara Therapeutics, Inc. 10K Form

Sell
23

TARA
Protara Therapeutics, Inc.

Last Price:
$5.11
Seasonality Move:
-16.66%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TARA News And Ratings

See the #1 stock for the next 7 days that we like better than TARA

TARA Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-17M
Price / Cash Flow: 0
Annual Sales: $3.67
Price / Book: 1.43

Profitability

EPS (TTM): -1.33610
Net Income (TTM): $-57.4M
Gross Margin: $-362K
Return on Equity: -35.96%
Return on Assets: -33.35%

Protara Therapeutics, Inc. Earnings Forecast

Key Protara Therapeutics, Inc. Financial Ratios

  • Per Share Earnings over the last 14 years have been positive in 8 years.

Protara Therapeutics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: TARA
CUSIP: 74365U
Website: protaratx.com

Debt

Debt-to-Equity Ratio: 0.02
Current Ratio: 14.58
Quick Ratio: 14.34

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

TARA Technical Analysis vs Fundamental Analysis

Sell
23
Protara Therapeutics, Inc. (TARA) is a Sell

Is Protara Therapeutics, Inc. a Buy or a Sell?